Ligand Pharma's total assets for Q1 2025 were $905.43M, a decrease of -3.86% from the previous quarter. LGND total liabilities were $109.90M for the fiscal quarter, a -1.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.